mitoxantrone has been researched along with Renal Insufficiency, Chronic in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, H | 1 |
| Katoh, T | 1 |
| Hirano, I | 1 |
| Hasegawa, A | 1 |
| Tsujita, T | 1 |
| Yamamoto, M | 1 |
| Shimizu, R | 1 |
1 other study available for mitoxantrone and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Induction of erythropoietin gene expression in epithelial cells by chemicals identified in GATA inhibitor screenings.
Topics: Anemia; Animals; Base Sequence; Cells, Cultured; CRISPR-Cas Systems; Epithelial Cells; Erythropoieti | 2017 |